Tag: Roszdravnadzor

Few cases of counterfeit drugs to get into circulation via internet in Russia

counterfeit drug
The amount of substandard medicines available on the market has been halved in 2017, while some falsified drugs get into circulation via the Internet, said Mikhail Murashko, the Head of Roszdravnadzor.

Roszdravnadzor is authorized to make control purchases of drugs

The Russian State Duma adopted in the first reading a draft law that authorizes Roszdravnadzor to make control purchases, which will allow to combat the sales of substandard medicines

Mandatory labeling for 7 nosologies may be introduced in 2018

drug marking
In 2020, the labeling of medicinal products will become mandatory for all manufacturers. But, for some drugs, including the expensive medicines, it may happen as early as in 2018

Counterfeit products will even not get into the licensed pharmacy chains

Russian State Duma adopted a bill on labeling of medicinal products with Data Matrix labels. This procedure will become mandatory from January 1, 2020

Drug labeling allowed to detect illegal resale of expensive medicines

A joint operation uncovered the illegal resale of expensive drugs MabThera and Acerbia

Russian drug labeling system is ready to operate at its full capacity

The drug labeling system was finalized in accordance with the functional requirements of the Russian Ministry of Health and Roszdravnadzor

Roszdravnadzor expects savings from the labeling of medicinal products

Roszdravnadzor expects that the total savings from the introduction of labeling of medicinal products will amount to several billion rubles a year

Russia defines objectives for control over circulation of biomed cell products

biomedical cells products
Russian Prime Minister Dmitry Medvedev signed a Decree defining the objectives for state control over the circulation of biomedical cell products

Availability of vital and essential drugs in Russia is 65% on average

The number of regions in Russia with the availability of vital and essential drugs below the national average level has increased

Labeling will become a compulsory process in Russia from 2018

The labeling system for medicinal products will become compulsory from 2018, said Mikhail Murashko, the Head of Federal Service for Surveillance in Healthcare

First labeled drugs go on sale in retail pharmacies in Russia

marked drugs
The first lot of labeled medicinal products went on sale in some pharmacies, and the first labeled drug sold at retail was Omez.

Roszdravnadzor detected and recalled 2 counterfeit drugs in H1

fake drugs
The Federal Service for Surveillance in Healthcare released the results of state control (surveillance) over the circulation of medicinal products for H1 2017

Roszdravnadzor seizes counterfeit Xymelin

the Federal Service for Surveillance in Healthcare informs on the need to withdraw from circulation a counterfeit medicinal product “Xymelin

Russia modified its approach to state supervision over the drug circulation

Russian Federation will use a risk-oriented approach regarding legal entities and individual entrepreneurs while performing the federal state supervision over the circulation of medicines for human use

Many vaccines in Russia are rejected because of inadequate transportation

The increased number of rejected vaccines can be explained by stricter requirements for their transportation

Russia will use risk-oriented approach for medical devices circulation control

government russia
Dmitry Medvedev signed a document, which establishes that Roszdravnadzor would use a risk-oriented approach for the state control of legal entities and individual entrepreneurs in the area of circulation of medical devices